Tag: Healthcare Logistics

Release – The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

Posted on by aweinsoff@channelchek.com

Research News and Market Data on TOI

Feb 23, 2026

PDF Version

CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has served on the board of several private and public healthcare companies including SeaSpine, Coherus BioSciences, Ob Hospitalist Group and most recently, VytlOne.

“We are thrilled to welcome Kim to our Board of Directors,” said Daniel Virnich, MD, CEO of The Oncology Institute. “Her deep experience in both oncology and pharmacy services are particularly relevant at this point in TOI’s journey as we expand our care delivery model across employed and MSO networks and grow our pharmacy business. Kim’s proven track record of expanding access, improving cost management, and advancing integrated care delivery models, will be invaluable as to our company and further strengthen our already outstanding board of directors.”

“It’s an honor to have been selected as a Board member of The Oncology Institute,” said Ms. Tzoumakas. “I look forward to utilizing my background and experience in healthcare services to advise this dedicated team and help them accomplish their mission of improving cancer outcomes and streamlining the patient journey.”

About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors
ICR Healthcare
TOI@icrhealthcare.com

UPS to Acquire Andlauer Healthcare Group for $1.6B, Bolstering Cold Chain Logistics Leadership

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– UPS will acquire Canada-based Andlauer Healthcare Group for $1.6B to strengthen cold chain and healthcare logistics capabilities.
– The deal gives UPS deeper access to Canadian markets and expands its global healthcare supply chain footprint.
– AHG’s founder Michael Andlauer will continue to lead operations post-acquisition, helping to integrate and scale services under UPS Healthcare.

UPS is taking a significant leap forward in healthcare logistics with its agreement to acquire Canada-based Andlauer Healthcare Group (AHG) for approximately $1.6 billion USD (CAD $2.2 billion). The deal, set to close in the second half of 2025, marks a strategic expansion of UPS Healthcare’s cold chain capabilities and its broader push to become the global leader in complex healthcare logistics.

Under the terms of the acquisition, AHG shareholders will receive CAD $55.00 per share in cash, a substantial premium that reflects the value of AHG’s specialized supply chain and third-party logistics offerings tailored to the healthcare sector. The transaction is subject to shareholder approval and regulatory clearance but has already secured support from AHG’s controlling shareholder, Michael Andlauer.

This acquisition arrives at a critical moment for healthcare logistics. Demand for temperature-sensitive and high-precision delivery of pharmaceuticals, biologics, and medical devices has grown rapidly in recent years, driven by the rise of advanced therapies, clinical trials, and global vaccine distribution efforts. UPS is positioning itself to meet those demands with a highly integrated global network, now enhanced by AHG’s robust infrastructure and expertise.

AHG brings to the table a coast-to-coast Canadian distribution network, a suite of customized logistics solutions, and proven cold chain transportation capabilities. These services will become part of UPS Healthcare’s expanding footprint, which already boasts over 19 million square feet of cGMP and GDP-compliant distribution space across the globe.

Michael Andlauer, AHG’s founder and CEO, will continue to lead the company following the acquisition, heading UPS Canada Healthcare and helping to guide the integration. “UPS Healthcare and AHG employees share a similar customer and patient-centric culture,” said Andlauer. “Once the transaction is completed, the businesses will offer an even broader set of specialized logistics services to customers throughout Canada.”

Kate Gutmann, EVP and president of International, Healthcare and Supply Chain Solutions at UPS, said the move is aligned with UPS’s mission to be the premier global healthcare logistics provider. “This acquisition marks another important step in our declaration to be the number one complex healthcare logistics and premium international logistics provider in the world,” she said.

The acquisition is also expected to drive growth for UPS by expanding its cold chain capabilities and enhancing services for healthcare customers who require strict temperature control, visibility, and compliance throughout the logistics chain. As UPS builds out its global logistics infrastructure, this move strategically complements earlier investments in technology, infrastructure, and customer-driven healthcare solutions.

For investors in the healthcare logistics and small-cap space, the AHG acquisition underscores growing M&A interest in niche logistics providers with deep industry specialization. It also signals UPS’s continued focus on high-growth, high-margin sectors, and its commitment to staying ahead in the evolving global healthcare ecosystem.

Take a moment to take a look at more emerging growth healthcare companies by taking a look at Noble Capital Markets’ Research Analyst Robert LeBoyer’s coverage list.